Healthcare · Biotechnology · NASDAQ
| Market cap | $5.17B |
|---|---|
| Trailing P/E | — |
| FCF yield | -7.7% |
| Revenue growth (YoY) | -100.0% |
| EPS growth (YoY) | — |
| FCF/share growth (YoY) | — |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
CRISPR Therapeutics AG trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Thomas Suozzi | House | Sell | $50,001 - $100,000 | Sep 30, 2021 |
| Thomas Suozzi | House | Buy | $50,001 - $100,000 | Jun 30, 2021 |
| Marjorie Taylor Greene | House | Buy | $1,001 - $15,000 | Jan 21, 2021 |
| James M Inhofe | Senate | Sell | $15,001 - $50,000 | — |
| James M Inhofe | Senate | Buy | $15,001 - $50,000 | — |